SCHEMBL22402941

SCHEMBL22402941

CC(C)(C)n1ncnc1-c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.46
SRC P12931 2/20 0.46
KDR P35968 2/20 0.46
DAPK3 O43293 1/20 0.46
RIPK2 O43353 1/20 0.46
ABL1 P00519 1/20 0.46
EGFR P00533 1/20 0.46
CYP1A2 P05177 1/20 0.46
FYN P06241 1/20 0.46
YES1 P07947 1/20 0.46
LYN P07948 1/20 0.46
HCK P08631 1/20 0.46
PDGFRB P09619 1/20 0.46
FGR P09769 1/20 0.46
CYP2C9 P11712 1/20 0.46
PDGFRA P16234 1/20 0.46
PRKACA P17612 1/20 0.46
EPHB2 P29323 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAP2K2 P36507 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22530133 0.81 IDO1 (0.38) LCKSRCKDRRIPK2ABL1
SCHEMBL22403092 0.81 HPGD (0.46) SRCABL1CYP1A2MAPK14SMN1; SMN2
SCHEMBL26542947 0.77 KDM4E (0.45) SMN1; SMN2KDM4EEGLN2ALDH1A1LMNA
SCHEMBL22530233 0.76 HCAR3 (0.43) SMN1; SMN2KDM4EALDH1A1HTTPOLB
SCHEMBL3923342 0.71 GRIN2B (0.31)
SCHEMBL4483738 0.70 DRD1 (0.47) LCKSRCKDRDAPK3RIPK2
SCHEMBL28265876 0.69 LCK (0.41) LCKSRCKDRDAPK3RIPK2
SCHEMBL21720017 0.69 DAPK3 (0.33) LCKSRCKDRDAPK3RIPK2
SCHEMBL31617446 0.66 RIPK2 (0.48) LCKSRCKDRDAPK3RIPK2
SCHEMBL11281776 0.66 ALDH1A1 (0.53) SRCSMN1; SMN2KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11786575-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-17 US disclosed
US-20220211802-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2022-07-07 US disclosed
US-11331369-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2022-05-17 US disclosed
US-20200282016-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2020-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786575-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 LCK 4796/4885SRC 4758/4885KDR 4521/4885
US-20200282016-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 LCK 4796/4885SRC 4758/4885KDR 4521/4885
US-20220211802-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 LCK 4796/4885SRC 4758/4885KDR 4521/4885
US-11331369-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 LCK 4796/4885SRC 4758/4885KDR 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.